Statistics for An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis
Total visits
| views | |
|---|---|
| An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis | 59 |
Total visits per month
| views | |
|---|---|
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
File Visits
| views | |
|---|---|
| An OpenLabelDoseEscalation Study to Assess the Safety and Efficacy of IL22 Agonist F652 in Patients With Alcoholassociated Hepatitis.pdf | 8 |
| An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis.pdf | 5 |
| An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis.pdf | 4 |
Top country views
| views | |
|---|---|
| United States | 46 |
| Chile | 8 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Santiago | 8 |
| Alameda | 6 |
| Bow | 1 |
| Campbell | 1 |
| Sacramento | 1 |
| Silver Spring | 1 |
| Zapopan | 1 |